Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CARTO ENT System

K-Number: K161701 · 2016-10-24

ApplicantBiosense Webster
Decision Date2016-10-24
Product CodePGW
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

CARTO ENT System is the device name listed in this FDA 510(k) record. The listed applicant is Biosense Webster. It received FDA 510(k) clearance on 2016-10-24 under 510(k) number K161701. The device is classified under product code PGW. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CARTO ENT System?

CARTO ENT System is a medical device that received FDA 510(k) clearance on 2016-10-24. The listed applicant is Biosense Webster. The 510(k) number is K161701.

When did CARTO ENT System receive FDA 510(k) clearance?

CARTO ENT System received FDA 510(k) clearance on 2016-10-24, under 510(k) number K161701.

Who is the listed applicant for CARTO ENT System?

The FDA 510(k) record lists Biosense Webster as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CARTO ENT System?

The FDA product code for CARTO ENT System is PGW.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT02565069Identification for the Treatment of Complex ArrhythmiasCOMPLETEDNCT04750798An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac ArrhythmiasRECRUITINGNCT05565599An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial FibrillationACTIVE_NOT_RECRUITINGNCT06168942A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage EliminationSUSPENDEDNCT06455098A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)ACTIVE_NOT_RECRUITINGNCT07116525A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping CatheterRECRUITING

Other records listing Biosense Webster as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

PMA P030031catheter, percutaneous, cardiac ablation, for treatment of atrial flutterPMA P240006Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible ElectroporationPMA P210027Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillationK252972CARTO™ 3 EP Navigation System V8.4K254085CARTO™ 3 EP Navigation System V9.0 with PIU PlusPMA P990071Cardiac ablation percutaneous catheter

View all 35 devices →

Related Devices (Code: PGW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261540Cube 4D Navigation System, VirtuEye ProFiagon GmbHK253395Stealth AXiS™ ENT clinical applicationMedtronic Navigation, Inc.K243053Navient Image Guided Navigation System (ENT) (955-NC-NC)ClaronavK231862TruDi® Navigation System V3 (FG-2000-00)Acclarent, Inc.K223734ENT EMBrainlab AGK221037TruDi Shaver BladeAcclarent, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑